Fluindione and drug reaction with eosinophilia and systemic symptoms: an unrecognised adverse effect?

Eur J Clin Pharmacol. 2012 Jan;68(1):101-5. doi: 10.1007/s00228-011-1101-9. Epub 2011 Jul 27.

Abstract

Purpose: Fluindione is an oral vitamin K antagonist (indanedione derivative) exclusively marketed in France and Luxembourg, known to have immuno-allergic adverse effects such as hepatitis, fever or interstitial nephritis. A few cases of drug reaction with eosinophilia and systemic symptoms (DRESS) have been reported with fluindione. The aim of the present study was to investigate fluindione-induced DRESS cases reported in France and to describe their characteristics.

Methods: We searched for potential cases of DRESS with fluindione reported in the French pharmacovigilance database since 2000.

Results: Thirty-six cases of DRESS were included and concerned 17 women and 19 men. The mean age was 65 years (median: 68 years, range: 28-95 years). Kidneys and liver were the most frequent organs involved. Thirty-five cases were serious. In 5 cases, the effect was life-threatening. Most of the patients recovered. Fluindione was the only medicine suspected in 26 cases. Skin patch tests, performed in 10 cases, were positive with fluindione in 9 cases.

Conclusions: Fluindione is not known to be a frequent cause of DRESS. However, the number of reports found is probably underestimated. The seriousness of DRESS, as all immuno-allergic adverse effects, contraindicates fluindione reintroduction. Coumarinic derivatives are the alternatives in patients who need oral anticoagulant treatment.

MeSH terms

  • Administration, Oral
  • Adult
  • Adverse Drug Reaction Reporting Systems
  • Aged
  • Aged, 80 and over
  • Anticoagulants / administration & dosage
  • Anticoagulants / adverse effects*
  • Drug Eruptions / etiology*
  • Drug Eruptions / therapy
  • Drug Hypersensitivity / diagnosis
  • Drug Hypersensitivity / physiopathology*
  • Drug Hypersensitivity / therapy
  • Eosinophilia / chemically induced
  • Eosinophilia / etiology*
  • Eosinophilia / therapy
  • Female
  • France
  • Humans
  • Male
  • Middle Aged
  • Pharmacovigilance*
  • Phenindione / administration & dosage
  • Phenindione / adverse effects
  • Phenindione / analogs & derivatives*
  • Retrospective Studies
  • Severity of Illness Index
  • Skin Tests
  • Vitamin K / antagonists & inhibitors*

Substances

  • Anticoagulants
  • Vitamin K
  • Phenindione
  • fluindione